ATE307809T1 - Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung - Google Patents

Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung

Info

Publication number
ATE307809T1
ATE307809T1 AT99954472T AT99954472T ATE307809T1 AT E307809 T1 ATE307809 T1 AT E307809T1 AT 99954472 T AT99954472 T AT 99954472T AT 99954472 T AT99954472 T AT 99954472T AT E307809 T1 ATE307809 T1 AT E307809T1
Authority
AT
Austria
Prior art keywords
pyrimidine derivatives
production
novel pyrimidine
novel
possess
Prior art date
Application number
AT99954472T
Other languages
English (en)
Inventor
Jong Wook Lee
Bong Yong Lee
Chang Seop Kim
Seung Kyu Lee
Song Jin Lee
Original Assignee
Yuhan Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuhan Corp Ltd filed Critical Yuhan Corp Ltd
Application granted granted Critical
Publication of ATE307809T1 publication Critical patent/ATE307809T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99954472T 1998-11-17 1999-11-09 Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung ATE307809T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019980049164A KR100272471B1 (ko) 1998-11-17 1998-11-17 신규의 피리미딘 유도체 및 그의 제조방법
PCT/KR1999/000669 WO2000029403A1 (en) 1998-11-17 1999-11-09 Novel pyrimidine derivatives and processes for the preparation thereof

Publications (1)

Publication Number Publication Date
ATE307809T1 true ATE307809T1 (de) 2005-11-15

Family

ID=36201265

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99954472T ATE307809T1 (de) 1998-11-17 1999-11-09 Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung

Country Status (17)

Country Link
US (1) US6545008B1 (de)
EP (1) EP1131312B1 (de)
JP (1) JP2002530280A (de)
KR (1) KR100272471B1 (de)
CN (1) CN1159312C (de)
AT (1) ATE307809T1 (de)
AU (1) AU762098B2 (de)
BR (1) BR9915323A (de)
CA (1) CA2351644A1 (de)
DE (1) DE69927997T2 (de)
ES (1) ES2251234T3 (de)
HK (1) HK1041000B (de)
HU (1) HUP0104533A3 (de)
MX (1) MXPA01004457A (de)
RU (1) RU2236407C2 (de)
TR (1) TR200101388T2 (de)
WO (1) WO2000029403A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0110338D0 (en) * 2001-04-27 2001-06-20 Sb Pharmco Inc Novel processes
US20070161637A1 (en) * 2003-07-22 2007-07-12 Neurogen Corporation Substituted pyridin-2-ylamine analogues
AU2004285394B2 (en) 2003-11-03 2009-01-08 Astrazeneca Ab Imidazo (1,2-A) pyridine derivatives for the treatment of silent gastro-esophageal reflux
JP5335426B2 (ja) * 2005-09-27 2013-11-06 アイアールエム・リミテッド・ライアビリティ・カンパニー ジアリールアミン含有化合物および組成物、ならびにc−kit受容体のモジュレーターとしてのそれらの使用
RU2586276C2 (ru) 2009-07-09 2016-06-10 Раквалиа Фарма Инк. Антагонист кислотного насоса для лечения заболеваний, связанных с патологическим нарушением моторики желудочно-кишечного тракта
SG10201600149VA (en) 2012-11-21 2016-02-26 Ptc Therapeutics Inc Substituted reverse pyrimidine bmi-1 inhibitors
WO2015030847A1 (en) * 2013-08-30 2015-03-05 Ptc Therapeutics, Inc. Substituted pyrimidine bmi-1 inhibitors
WO2015076800A1 (en) 2013-11-21 2015-05-28 Ptc Therapeutics, Inc. Substituted pyridine and pyrazine bmi-1 inhibitors
CA3109386A1 (en) 2018-08-17 2020-03-19 Ptc Therapeutics, Inc. Use of 5-fluoro-2-(6-fluoro-2-methyl-1h-benzo(d)imidazol-1-yl)-n4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine in the treatment of pancreatic cancer

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3980781A (en) 1966-03-31 1976-09-14 Imperial Chemical Industries Limited Fungicidal composition and method containing 2-amino-pyrimidines
US4000138A (en) 1966-03-31 1976-12-28 Imperial Chemical Industries Limited Organic compounds and compositions containing them
GB1182584A (en) 1966-03-31 1970-02-25 Ici Ltd Pyrimidine derivates and the use thereof as fungicides
US4044136A (en) 1972-09-09 1977-08-23 Pfizer Inc. Aminoquinazoline therapeutic agents
GB1383409A (en) 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
US3956495A (en) 1973-10-30 1976-05-11 Eli Lilly And Company 2,4-Diaminoquinazolines as antithrombotic agents
US4755218A (en) 1985-12-31 1988-07-05 Monsanto Company Haloacyl 1-substituted-1,2,3,4-tetrahydro-isoquinolines as herbicide antidotes
US4966622A (en) 1988-04-12 1990-10-30 Ciba-Geigy Corporation N-phenyl-N-pyrimidin-2-ylureas
FR2640582B1 (fr) 1988-12-21 1991-08-16 Gerard Megret Procede d'habillage d'elements de boites montees et installation pour la mise en oeuvre de ce procede
ES2081863T3 (es) 1989-03-22 1996-03-16 Ciba Geigy Ag Plaguicidas.
GB8910722D0 (en) 1989-05-10 1989-06-28 Smithkline Beckman Intercredit Compounds
GB9012592D0 (en) 1990-06-06 1990-07-25 Smithkline Beecham Intercredit Compounds
DK0556310T3 (da) 1990-11-06 1995-08-21 Pfizer Quinazolinderivater til forhøjelse af antitumoraktivitet
AU653601B2 (en) 1991-04-17 1994-10-06 Pfizer Inc. Pyrimidine derivatives for enhancing antitumor activity
US5276186A (en) 1992-03-11 1994-01-04 Ciba-Geigy Corporation Process for the production of guanidine derivatives
KR0144833B1 (ko) * 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
ES2114662T3 (es) 1993-08-26 1998-06-01 Ono Pharmaceutical Co Derivados de la 4-aminopirimidina.
WO1995010506A1 (en) 1993-10-12 1995-04-20 The Du Pont Merck Pharmaceutical Company 1n-alkyl-n-arylpyrimidinamines and derivatives thereof
DE69530989T2 (de) * 1994-08-13 2004-05-19 Yuhan Corp. Neue pyrimidinderivate und verfahren zu ihrer herstellung
DE69706981T2 (de) * 1996-05-04 2002-06-06 Yuhan Corp., Seoul/Soul Verfahren zur herstellung von pyrimidin-derivaten
BR9712392A (pt) * 1996-10-29 2000-01-25 Yuhan Corp Processos para preparar 5,6-dimetil-2-(4-fluorofenil-amino) -4- (1-metil-1,2,3,4 - tetraidroisoquinolin - 2 -il) pirimidina, 4 - halogeno - 2 - (4 - fluorofenilamino) -5,6 -dimetil-pirimidina e 1-metil-1,2,3,4-tetraidroisoquinolina, e, derivado de pirimidina
IN188411B (de) 1997-03-27 2002-09-21 Yuhan Corp

Also Published As

Publication number Publication date
WO2000029403A1 (en) 2000-05-25
BR9915323A (pt) 2001-08-07
KR100272471B1 (ko) 2000-11-15
TR200101388T2 (tr) 2001-10-22
JP2002530280A (ja) 2002-09-17
DE69927997D1 (de) 2005-12-01
AU762098B2 (en) 2003-06-19
AU1081200A (en) 2000-06-05
MXPA01004457A (es) 2004-04-05
ES2251234T3 (es) 2006-04-16
EP1131312B1 (de) 2005-10-26
KR20000032633A (ko) 2000-06-15
HK1041000A1 (en) 2002-06-28
CN1159312C (zh) 2004-07-28
CA2351644A1 (en) 2000-05-25
HUP0104533A3 (en) 2003-01-28
HK1041000B (zh) 2004-12-31
EP1131312A1 (de) 2001-09-12
HUP0104533A2 (hu) 2002-04-29
RU2236407C2 (ru) 2004-09-20
US6545008B1 (en) 2003-04-08
CN1326453A (zh) 2001-12-12
DE69927997T2 (de) 2006-07-27

Similar Documents

Publication Publication Date Title
ATE229017T1 (de) Farnesyltransferase-inhibitoren mit piperidinstruktur und verfahren zu ihrer herstellung
WO2003037860A3 (en) Purine analogs having hsp90-inhibiting activity
YU84703A (sh) Oralni rastvor aripiprazola
CA2334773A1 (en) Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
WO2001047928A3 (de) Imidazo 1,3,5 triazinone und ihre verwendung
ATE202337T1 (de) Cyclopropylalkansäurederivate
PT894084E (pt) Derivados de acido cinamico e sua utilizacao como antagonistas de integrina
CA2005986A1 (en) Benzimidazole derivative with gastric acid inhibitory effect and process for its preparation
WO2001095856A3 (en) Urea derivative useful as an anti-cancer agent and process for preparing same
WO2001027110A3 (de) Am sechsring substituierte, bicyclische imidazo-3-yl-aminderivate
DE50113943D1 (de) 4-alkoxy-cyclohexan-1-amino-carbonsäureester und verfahren zu ihrer herstellung
HK1046902A1 (zh) 新型哌嗪基烷基硫代嘧啶衍生物,包含該衍生物的藥物組合物以及製備該活性物質的方法
ATE307809T1 (de) Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung
ATE310010T1 (de) 6-0-substitutierte eryththromycin-verbindungen und verfahrenen zu ihrer herstellung
EP1019047A4 (de) Antithrombotische mittel
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
WO2001085095A3 (en) Chiral fluoroquinolizinone arginine salt forms
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
ATE214051T1 (de) Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
EP1123923A4 (de) Dihydropyridin-derivate und drogen gemenge, die diese enthalten
AU7470098A (en) Antithrombotic agents
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
AU1434201A (en) Antithrombotic agents
DE69824410D1 (en) Antithrombosemittel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties